(Q51120036)

30 March 2018

title

Potentiation of the l-Dopa effect in man by the use of catechol-O-methyltransferase inhibitors (English)

1 reference

https://api.crossref.org/works/10.1016/0022-510X(71)90088-8

19 December 2023

1 reference

https://api.crossref.org/works/10.1016/0022-510X(71)90088-8

19 December 2023

author name string

A. D. Ericsson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5112212

19 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=5112212

19 December 2023

publication date

1 October 1971

1 reference

30 March 2018

full work available at URL

https://api.elsevier.com/content/article/PII:0022510X71900888?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0022-510X(71)90088-8

https://api.elsevier.com/content/article/PII:0022510X71900888?httpAccept=text/plain

19 December 2023

1 reference

https://api.crossref.org/works/10.1016/0022-510X(71)90088-8

Journal of the Neurological Sciences

19 December 2023

published in

1 reference

30 March 2018

volume

14

1 reference

30 March 2018

issue

2

1 reference

30 March 2018

page(s)

193-197

1 reference

30 March 2018

Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0022-510X(71)90088-8

Reversal of the reserpine syndrome with L‐dopa metabolites in reserpinized rats

19 December 2023

4

1 reference

https://api.crossref.org/works/10.1016/0022-510X(71)90088-8

Phenomena of the Hypokinetic Rigid Type caused by O-methylation of Dopamine in the Para-position

19 December 2023

5

1 reference

https://api.crossref.org/works/10.1016/0022-510X(71)90088-8

Relation between the structure of certain methoxyphenylethylaminederivatives and the occurrence of a hypokinetic rigid syndrome

19 December 2023

6

1 reference

https://api.crossref.org/works/10.1016/0022-510X(71)90088-8

Relation between the action of dopamine and apomorphine and their O-methylated derivatives upon the CNS

19 December 2023

7

1 reference

https://api.crossref.org/works/10.1016/0022-510X(71)90088-8

Dopa and 3-O-methyldopa in cerebrospinal fluid of parkinsonism patients during treatment with oral l-dopa

19 December 2023

8

1 reference

https://api.crossref.org/works/10.1016/0022-510X(71)90088-8

Clinical and cerebrospinal fluid changes in parkinsonian patients treated with L‐3, 4‐dihydroxyphenylalanine (L‐dopa)

19 December 2023

9

1 reference

https://api.crossref.org/works/10.1016/0022-510X(71)90088-8

Drug-Induced Changes of Extracerebral Dopa Metabolism in Man

19 December 2023

11

1 reference

https://api.crossref.org/works/10.1016/0022-510X(71)90088-8

Catecholamines and neurologic diseases.

19 December 2023

13

1 reference

https://api.crossref.org/works/10.1016/0022-510X(71)90088-8

19 December 2023

Identifiers

1 reference

30 March 2018

1 reference

30 March 2018